Brown Todd M, Parmar Gaurav, Durant Raegan W, Halanych Jewell H, Hovater Martha, Muntner Paul, Prineas Ronald J, Roth David L, Samdarshi Tandaw E, Safford Monika M
University of Alabama at Birmingham, Division of Cardiovascular Diseases, USA.
J Health Care Poor Underserved. 2011 Nov;22(4):1179-89. doi: 10.1353/hpu.2011.0127.
Individuals with cardiovascular disease (CVD) living in Health Professional Shortage Areas (HPSA) may receive less preventive care than others. The Reasons for Geographic And Racial Differences in Stroke Study (REGARDS) surveyed 30,239 African American (AA) and White individuals older than 45 years of age between 2003-2007. We compared medication use for CVD prevention by HPSA and insurance status, adjusting for sociodemographic factors, health behaviors, and health status. Individuals residing in partial HPSA counties were excluded. Mean age was 64±9 years, 42% were AA, 55% were women, and 93% had health insurance; 2,545 resided in 340 complete HPSA counties and 17,427 in 1,145 non-HPSA counties. Aspirin, beta-blocker, and ACE-inhibitor use were similar by HPSA and insurance status. Compared with insured individuals living in non-HPSA counties, statin use was lower among uninsured participants living in non-HPSA and HPSA counties. Less medication use for CVD prevention was not associated with HPSA status, but less statin use was associated with lack of insurance.
生活在医疗专业人员短缺地区(HPSA)的心血管疾病(CVD)患者可能比其他人接受的预防性护理更少。中风地理和种族差异原因研究(REGARDS)在2003年至2007年间对30239名45岁以上的非裔美国人(AA)和白人进行了调查。我们比较了按HPSA和保险状况划分的用于预防CVD的药物使用情况,并对社会人口统计学因素、健康行为和健康状况进行了调整。居住在部分HPSA县的个体被排除在外。平均年龄为64±9岁,42%为非裔美国人,55%为女性,93%有医疗保险;2545人居住在340个完整的HPSA县,17427人居住在1145个非HPSA县。阿司匹林、β受体阻滞剂和ACE抑制剂的使用在HPSA和保险状况方面相似。与居住在非HPSA县的参保个体相比,居住在非HPSA县和HPSA县的未参保参与者中他汀类药物的使用较低。用于预防CVD的药物使用较少与HPSA状况无关,但他汀类药物使用较少与缺乏保险有关。